Non-typeable Haemophilus influenzae (NTHi) is a leading causative organism of opportunistic 14 respiratory tract infections, including otitis media and acute exacerbations of chronic 15 obstructive pulmonary disease. Despite the enormous disease burden associated with NTHi 16 infections, there are currently no effective prevention strategies, and the rapid development of 17 antibiotic resistance is compromising treatment.
competitive studies (29) (30) (31) . Bacterial suspensions of ~1.0 OD 600 were made in TSB from 8-89 10 hr growth on CA and diluted 1:10 in 5 pre-warmed sTSB (5 mL). Broths were incubated 90 for 12 hr at 37°C aerobically with shaking (220 RPM), centrifuged at 4000 × g for 5 min at 91 37°C and resuspended in fresh, pre-warmed TSB to an OD 600 of 1.0 prior to use in growth 92 experiments.
94
Determination of NTHi-inhibitory activity 95 A well diffusion assay of the extracted HPL protein was used to categorise Hh strains 96 containing the HPL ORF as either HPL-producers (Hh-HPL + ) or non-producers (Hh-HPL -), as 97 previously described (28). This assay was also used to establish the relative inhibitory activity 98 of each strain. Testing was conducted on two indicator NTHi strains (ATCC 49427 and clinical 99 isolate NTHi-L15). Two Hh strains were included as additional HPL ORF negative controls 100 for HPL extraction: Hh ATCC 33390 and BW1 HPL-. HPL open reading frame (ORF). The targets used for discrimination of Hh (hypD) and NTHi 105 (siaT) have previously been described and validated (32) . For detection of the HPL ORF, 106 primers were designed based on the HPL ORF of Hh-BW1 (29) (GenBank MN720274). The 107 FAM, HEX and TET channels were used for simultaneous fluorescence detection of siaT, hypD 108 and HPL, respectively. Primer and probe sequences are detailed in Table 1 . Primer specificity 109 was confirmed by discontiguous megaBLAST analysis and PCR of a panel of Haemophilus 110 spp. and multiple genera representing common upper respiratory tract flora. PCR assays were 111 extensively optimised and evaluated for detection/quantification limits in triplex format.
112
PCRs were performed using the CFX96 Touch TM real- Hh-HPLand 100 µL of NTHi ATCC 49247 to 5 mL pre-warmed sTSB containing 0.0, 0.9, The HPL amplicon was confirmed to be specific and sensitive for the detection of the five 197 previously identified HPL sequence variants (29) by in silico investigations and by PCR.
198
Specificity of the HypD and SiatT targets was also confirmed by PCR. Complete results of 199 PCR assay validation is detailed in supplementary materials. The low limit of quantification 200 values for the HypD and SiaT assays in triplex format were 2 × 10 -5 ng and 2 × 10 -4 ng, 201 corresponding to 10 and 100 GE respectively. The lower limit of detection for the HPL assay 202 was 10 GE ( Figure S1 ). The upper limits of detection/quantification were not explicitly 203 determined as expected DNA levels from sample were unlikely to exceed the maximum 2 ng 204 tested.
205
Given the high volume of samples generated from growth experiments, a cheap and high-206 throughput DNA extraction method was required to reliably distinguish and quantify NTHi 207 and Hh in co-culture. Extraction utilizing thermal lysis has previously been shown to be an 208 efficient and cost-effective method to harvest bacterial DNA for quantitative real-time PCR 209 from suspensions of several bacterial species in a range of sample matrices (36-41). Crude
210
DNA extraction methods are also prone to contamination with PCR inhibitors originating from 211 sample matrices (39, 42) . There are also reports of intra-and inter-species differences in DNA 212 extractions efficiencies (39, 42, 43) . PCR quantification of gDNA extracted by thermal lysis 213 was validated and found to be comparable to quantification by OD600 and colony counts. Full 214 details of thermal extraction validation are available in supplementary materials.
215
Baseline NTHi-inhibitory activity of Hh-HPL + strains 216 We previously discovered a number of distinct genetic variations of the HPL ORF with varying Figure S5 ).
225

HPL-production mediates NTHi growth inhibition and a competitive advantage in 226
Hh 227 The growth rate of NTHi was significantly impaired during competition with all Hh-HPL + 228 strains, compared to growth without competition (p < 0.0001) ( Figure 1A ). This inhibitory 229 effect was more pronounced during competition with highly bioactive strains (Hh-BW1 and Hh; for these species survival in the URT niche is dependent on their ability to outcompete host 237 proteins and co-existing bacterial populations for heme (20) . We previously demonstrated that 238 the NTHi-inhibitory mechanism of HPL is associated with it's ability to bind heme in a form 239 inaccessible to NTHi and that inhibitory activity is lost in conditions where heme concentration 240 exceeds the binding capacity of HPL (29). While levels of heme/iron are considered to be low 241 in the respiratory tract, there is indirect evidence for increased heme/iron levels in airways of 242 smokers, COPD and CF which may contribute to increased susceptibility to infection in these 243 individuals (44). Thus, it was important to assess the effectiveness of HPL with varying 244 concentrations of heme to ensure probiotic effectiveness in a range of in vitro conditions 245 reflecting possible in vivo scenarios. The NTHi-inhibitory capacity of HPL was maintained 246 even in conditions of high heme-availability (15 µg mL -1 ), albeit to a lesser degree than lower 247 heme concentrations (0.0-3.8 µg/mL) ( Figure 1A ). This suggests that levels of HPL produced 248 by Hh are sufficient to limit NTHi's access to heme in a dynamic in vitro system, even under 249 excess heme conditions unlikely to be encountered in vivo (44).
250
Interestingly, Hh-HPL + strains exhibited a pattern of enhanced growth in response to NTHi 251 competition (p <0.0001) ( Figure 1B) . This effect was observed in all heme concentrations and 252 was more pronounced in the highly inhibitory Hh-HPL + strains. The converse was observed in 253 Hh-HPLstrains, where they exhibited poorer growth in response to competition with NTHi 254 ( Figure 1D ). This may be a reflection of the highly efficient set of heme-scavenging systems 255 possessed by NTHi that outcompete Hh in the absence of HPL.
257
NTHi-inhibitory capacity is associated with expression of HPL 258
To further test whether the observed competitive advantage of Hh-HPL + strains could be 259 attributed to HPL production, HPL expression was quantified by reverse transcription and real-260 time PCR during competitive growth with NTHi. The hypD target was validated as the 261 housekeeper gene ( Figure S6A ) and the optimal growth phase for HPL expression analysis was 262 determined ( Figure S6B ).
263
Baseline expression of HPL was highest in the highly bioactive strains (Hh-BW1 and Hh-264 RHH122), significantly lower in Hh-NF5 (p <0.0001), and completely absent in Hh-NF4 265 (Figure 2A) . These results establish a connection between expression of HPL and NTHi- NTHi, an effect that was more pronounced in Hh-BW1 and Hh-RHH122 ( Figure 2B ). This 269 may explain the enhanced growth of Hh-HPL + strains in response to NTHi during the short-270 term competition assays ( Figure 1C) . These results show that expression of HPL has a 271 significant impact on the NTHi-inhibitory capacity of Hh-HPL + strains and therapeutic utility 272 in an in vivo setting. Therefore, the huge differential expression of HPL amongst Hh-HPL + 273 strains must be considered when selecting a probiotic candidate. However, our understanding 274 of HPL regulation is still rudimentary. Further investigation into potential upstream regulatory 275 components or post-translational modification is needed to elucidate the inter-strain differences 276 in HPL production and/or biological activity despite complete ORF sequence homology.
278
NTHi fitness dramatically decreases in competition with HPL-producers 279
Short-term competition may highlight the potency of HPL-mediated inhibition but is not 280 representative of in vivo competition dynamics. Thus, a longer-term study was employed to 281 assess the competition between NTHi and Hh-HPL + over a period of 6 days (12 generations).
282
The competitive advantage of Hh-HPL+ strains was evident within the 2 nd (24 hours) and 4 th 283 generations (48 hours) with highly bioactive Hh-HPL + , or the intermediate Hh-HPL + , 284 respectively ( Figure 3A) . The stunted inhibitory activity exhibited by Hh-NF5 may be 285 attributed to lower levels of HPL production over the course of the assay. The fitness of NTHi 286 over subsequent generations decreases significantly until complete loss of fitness during the 287 final generations. Although, competition with Hh-HPLdid not result in a significant loss of 288 fitness over the 6-day period, there was decrease in fitness of all Hh-HPL strains at 24 hours, 289 followed by complete recovery ( Figure 3A ). This may have arisen from competition for heme 290 prior to the onset of maximum HPL production.
291
To show that loss of fitness of NTHi was not unique to NTHi strain ATCC 49247, additional 292 reference strains NCTC 11315 and ATCC 49766 were tested in competition with Hh-BW1.
293
All three NTHi strains responded in the same manner, culminating in a total loss of fitness at 294 the end of the 6-day period ( Figure 3B ). 
